RxDoctor Payments Data

Bret Guidry, MD

Psychiatry · Rock Hill, SCNPI 1588634554

Payments from drug & device makers

$4,386in general payments, 2019–2025

Across 65 payments — averaging $67.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$361
  • AbbVie$194
  • Takeda Pharmaceuticals U.S.A., Inc.$172
  • Otsuka America Pharmaceutical, Inc.$154
  • Teva Pharmaceuticals USA, Inc.$124
  • plus $381 from 7 others

What the payments were for

  • Food & beverage$1,35931%
  • Education$271%
  • Other$3,00068%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,386 in reported general payments places this provider in the 85th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$48,503
Medicare patients
57
Services billed
495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl18$27,096
RexultiBrexpiprazole12$17,321
TrintellixVortioxetine Hydrobromide25$13,189
Lurasidone Hcl15$9,865
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine43$2,642
Bupropion XlBupropion Hcl76$1,874
Trazodone Hcl112$1,820
Clozapine35$1,296
Divalproex Sodium ErDivalproex Sodium33$1,094
Duloxetine Hcl70$911
Venlafaxine Hcl ErVenlafaxine Hcl42$879
Fluoxetine Hcl106$844
Methylphenidate ErMethylphenidate Hcl14$843
Quetiapine Fumarate77$842
Paroxetine Hcl44$742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$194$27,09618 claims
Otsuka America Pharmaceutical, Inc.Rexulti$154$17,32112 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$172$13,18925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →